Skip to content
Clinical Trials – home
Sint Franciscus Vlietland Groep Stichting
Sponsor

Sint Franciscus Vlietland Groep Stichting

The Netherlands Kleiweg 500, 3045 PM Rotterdam, The Netherlands

About the sponsor

Research activity includes prevention of lower respiratory tract infections and wheezing in moderate-late preterm infants, with attention to early-life respiratory vulnerability and immune development.

  • Preterm-born infants
  • Bacterial lysates
  • Respiratory infection prevention

The clinical focus is on reducing early recurrent respiratory illness in infants at increased risk of later airway symptoms.

About Specializations

Sint Franciscus Vlietland Groep Stichting runs clinical trials in conditions such as Hepatic fibrosis, Lower respiratory tract infection, Obesity, Metabolic surgery, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Study on the Effects of a Mediterranean Diet with Intermittent Fasting vs. Bupropion and Naltrexone in Overweight Patients with Type 2 Diabetes and Liver Fibrosis

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Bupropion Hydrochloride
  • Sponsor:Sint Franciscus Vlietland Groep Stichting

Study on Preventing Respiratory Infections and Wheezing in Late-Moderate Preterm Infants Using Bacterial Lysates

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years
  • Sponsor:Sint Franciscus Vlietland Groep Stichting

Obesity+1

Recruiting

Study on Tranexamic Acid and Sodium Chloride to Reduce Bleeding in Gastric Bypass Surgery for Patients with Severe Obesity

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Sodium Chloride
  • Sponsor:Sint Franciscus Vlietland Groep Stichting

Asthma

Recruiting

Study on Extending Dosing Intervals of Mepolizumab and Dupilumab for Patients with Severe Asthma

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Sint Franciscus Vlietland Groep Stichting

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.